Cite
HARVARD Citation
Branch, K. et al. (2022). Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post‐hoc analysis from the REWIND randomized trial. European journal of heart failure. pp. 1805-1812. [Online].